Biomega group is one of the leading bioscience companies producing high-quality ingredients for health and nutrition industries. Their latest whitepaper researches the positive effects of salmon peptides on cardiovascular disease (CVD) risk factors.
With an increasing prevalence of many chronic conditions worldwide, there is also a growing demand for nutraceuticals and functional foods that can help us combat those health conditions. Since peptides have so many essential bioregulatory roles and different regulatory mechanisms, they are the perfect candidate for investigating. Marine peptides have demonstrated antiviral, antimicrobial, immunomodulatory, neuroprotective, and many other qualities.
Cardiovascular diseases account for 3.9 million deaths in Europe each year, according to the European Heart Network. That makes up for 45% of all deaths in Europe, and it’s the number one cause of death.
The biggest risk factors for developing CVDs are unhealthy diet and an inactive lifestyle. Experts suggest that proper diet and exercise can help combat medical risks associated with CVDs such as high blood pressure and bad cholesterol.
“There is increasing science-backed evidence available that shows how functional food ingredients and supplements can help reduce the risk of CVD and coronary heart disease by lowering what’s known as the ‘bad’ low-density lipoprotein (LDL) cholesterol, while simultaneously improving the ‘good’ high-density lipoprotein (HDL) cholesterol,” said Bjorn Liaset, Director of R&D at Biomega.
“Our whitepaper explores how niacin, which is found at high levels in Biomega salmon peptides, can elevate good cholesterol to promote general heart wellness in humans. In addition, we also discuss how the anti-atherosclerotic properties of salmon peptides can aid in cardiovascular protection,” he continued.
The benefits of consuming fish have been known for a long time. However, they have mostly been attributed to high omega-3 fatty acid content. With new research focusing on the importance of peptides, we may find other essential molecules for improving physiological functioning. Salmon peptides can be beneficial for managing obesity, insulin regulation, skeletal system health, cardiovascular protection, and reducing inflammation.
Titled “Understanding Salmon Peptides and Cardiovascular Health,” this whitepaper is the first in a series of releases Biomega plans to publish to educate the general public on different health benefits salmon peptides can have on human and animal health.
The whitepaper highlights the effects of niacin since previous studies showed that it could lower LDL cholesterol. It can also increase high-density lipoprotein cholesterol (HDL-C) levels, which are often seen as “good” because they help eliminate LDL-C from the bloodstream.
With an increasing prevalence of obesity, diabetes, and cardiovascular diseases worldwide, it is crucial to find compounds that can help slow down and prevent the development of these conditions.
Marianne Warnaer, the Director of Global Sales at Biomega, thinks that it is their job as one of the leaders in bioscience industries to help the preventions of these chronic conditions with science-based information and top quality products.
To learn more about salmon peptides and other products that can help improve your health, visit the Biomega website.
